Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Brotchie

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Expert Review of Neurotherapeutics|June 4, 2010
Antidyskinetic actions of amantadine in Parkinson's disease: are benefits maintained in the long term?Jonathan Brotchie
International Review of Neurobiology|September 13, 2011
New approaches to therapyJonathan Brotchie, Peter Jenner
Neurology|February 18, 2009
Mechanisms compensating for dopamine loss in early Parkinson diseaseJonathan Brotchie, Cheryl Fitzer-Attas
Experimental Neurology|July 3, 2002
Protection of striatal neurons by joint blockade of D1 and D2 receptor subtypes in an in vitro model of cerebral hypoxiaSue Davis, Jonathan Brotchie, Ioan Davies
Idrugs : the Investigational Drugs Journal|December 1, 2004
Recent advances in the treatment of L-DOPA-induced dyskinesiaTimothy Brown, Carmen de Groote, Jonathan Brotchie
Neuroscience Letters|December 17, 2005
alpha2-Adrenoceptor-mediated modulation of the release of GABA and noradrenaline in the rat substantia nigra pars reticulataAmal Alachkar, Jonathan Brotchie, Owen T Jones
European Journal of Pharmacology|August 13, 2004
Effects of adenosine A1, dopamine D1 and metabotropic glutamate 5 receptors-modulating agents on locomotion of the reserpinised ratsNaila Ismayilova, Alan Crossman, Alexei Verkhratsky, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 5, 2002
Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's diseaseSusan H Fox, Brian Henry, Michael Hill, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2012
A critique of available scales and presentation of the Non-Human Primate Dyskinesia Rating ScaleSusan H Fox, Tom H Johnston, Qin Li, et al.
Biochemical and Biophysical Research Communications|May 20, 2008
Dietary resveratrol administration increases MnSOD expression and activity in mouse brainEllen L Robb, Lieke Winkelmolen, Naomi Visanji, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Expert Review of Neurotherapeutics|June 4, 2010
Antidyskinetic actions of amantadine in Parkinson's disease: are benefits maintained in the long term?Jonathan Brotchie
International Review of Neurobiology|September 13, 2011
New approaches to therapyJonathan Brotchie, Peter Jenner
Neurology|February 18, 2009
Mechanisms compensating for dopamine loss in early Parkinson diseaseJonathan Brotchie, Cheryl Fitzer-Attas
Experimental Neurology|July 3, 2002
Protection of striatal neurons by joint blockade of D1 and D2 receptor subtypes in an in vitro model of cerebral hypoxiaSue Davis, Jonathan Brotchie, Ioan Davies
Idrugs : the Investigational Drugs Journal|December 1, 2004
Recent advances in the treatment of L-DOPA-induced dyskinesiaTimothy Brown, Carmen de Groote, Jonathan Brotchie
Neuroscience Letters|December 17, 2005
alpha2-Adrenoceptor-mediated modulation of the release of GABA and noradrenaline in the rat substantia nigra pars reticulataAmal Alachkar, Jonathan Brotchie, Owen T Jones
European Journal of Pharmacology|August 13, 2004
Effects of adenosine A1, dopamine D1 and metabotropic glutamate 5 receptors-modulating agents on locomotion of the reserpinised ratsNaila Ismayilova, Alan Crossman, Alexei Verkhratsky, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 5, 2002
Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's diseaseSusan H Fox, Brian Henry, Michael Hill, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2012
A critique of available scales and presentation of the Non-Human Primate Dyskinesia Rating ScaleSusan H Fox, Tom H Johnston, Qin Li, et al.
Biochemical and Biophysical Research Communications|May 20, 2008
Dietary resveratrol administration increases MnSOD expression and activity in mouse brainEllen L Robb, Lieke Winkelmolen, Naomi Visanji, et al.
Pageof 2